Potential new target for smoking cessation without weight gain – 2
Narrator: This is NIH Health Matters. I’m Joe Balintfy. A new study in mice has identified a brain pathway that could be a target of new treatments for smoking and weight control. Dr. Nora Volkow, an institute director at NIH, explains that a nicotine-like drug specifically activated nicotine receptors in a brain center that controls feeding.
Volkow: Having a therapeutic intervention that would help with the urges to smoke while at the same time decrease the consumption of food could be very appealing in terms of success for smoking cessation therapies.
Narrator: She says one of the reasons why it’s difficult to quit is the fear of gaining weight. For study details, visit www.drugabuse.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.